SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-041304
Filing Date
2022-02-14
Accepted
2022-02-14 15:07:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d217480dsc13ga.htm SC 13G/A 31043
  Complete submission text file 0001193125-22-041304.txt   32544
Mailing Address P.O. BOX 150183 AUSTIN TX 78715
Business Address P.O. BOX 150183 AUSTIN TX 78715 512-809-8549
Lung Therapeutics, Inc. (Filed by) CIK: 0001611241 (see all company filings)

IRS No.: 461383209 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Subject) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91311 | Film No.: 22630185
SIC: 2834 Pharmaceutical Preparations